- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17.08. | Turn Therapeutics Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.08. | Turn Therapeutics Inc. GAAP EPS of -$0.20 | 3 | Seeking Alpha | ||
| 12.08. | Turn Therapeutics Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 28.07. | Turn Therapeutics Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 07.07. | Turn Therapeutics Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 01.06. | Turn Therapeutics: Positive Studiendaten zu Ekzem-Medikament treiben Aktie an | 3 | Investing.com Deutsch | ||
| 01.06. | Turn Therapeutics reports interim phase 2 data for eczema drug | 2 | Investing.com | ||
| TURN THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 27.05. | Turn Therapeutics publishes GX-03 dermatitis study results | 1 | Investing.com | ||
| 27.05. | Turn Therapeutics Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 19.05. | Turn Therapeutics Inc. - 8-K, Current Report | 4 | SEC Filings | ||
| 18.05. | Turn Therapeutics appoints former FDA chief Stephen Hahn | 3 | Investing.com | ||
| 11.05. | Turn Therapeutics Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 11.05. | Turn Therapeutics Inc. - 8-K, Current Report | - | SEC Filings | ||
| 31.03. | Turn Therapeutics Inc. GAAP EPS of -$0.12 beats by $0.01 | 3 | Seeking Alpha | ||
| 31.03. | Turn Therapeutics Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 31.03. | Turn Therapeutics Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 31.03. | Turn Therapeutics: $25 Million Financing Secured By Dermatology Biotechnology Company | 3 | pulse2.com | ||
| 24.03. | Turn Therapeutics secures up to $25M in financing from Avenue Capital Group | 1 | Seeking Alpha | ||
| 24.03. | Turn Therapeutics secures $25M loan facility from Avenue Capital | 1 | Investing.com | ||
| 24.03. | Turn Therapeutics Inc. - 8-K, Current Report | 1 | SEC Filings |
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TILRAY BRANDS | 3,925 | -0,13 % | Tilray Brands, Inc.: BrewDog triumphiert bei den World Beer Awards 2026 mit herausragender Braukunst | Hazy Jane, Wingman und Mackie's Two Scoops werden mit Goldmedaillen und dem Scotland Country Winner Award ausgezeichnet. Zu den besten Bieren der Welt zählen auch Punk IPA, Lost Lager, Black Heart und... ► Artikel lesen | |
| VIATRIS | 14,544 | +0,34 % | Dividendenbekanntmachungen (21.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACCO BRANDS CORPORATION US00081T1088 0,075 USD 0,0642 EUR ALLISON TRANSMISSION HOLDINGS INC US01973R1014 0,29 USD 0,2483 EUR AMGEN... ► Artikel lesen | |
| SYNBIOTIC | 0,698 | +1,90 % | Portfolio unwound; rating placed Under Review: Wave of portfolio insolvencies narrows SYNBIOTIC to WEECO ... | SYNBIOTIC's investment case has changed fundamentally after a wave of insolvencies and liquidations across the portfolio. What began with the Bushdoctor (Austria) insolvency in December 2025 has widened... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 11,805 | +1,42 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Announces Major Managed Medicare Payer Agreement for TONMYA | New agreement, effective January 1, 2027, to add approximately 9 million Medicare lives (16% of approximately 55 million Medicare lives in the U.S.) On top of two previously announced major commercial... ► Artikel lesen | |
| SELLAS LIFE SCIENCES | 13,100 | 0,00 % | When Revolution Medicines' FDA Win Lifts Other Boats: SELLAS Life Sciences Stock Surges | ||
| XORTX THERAPEUTICS | 1,920 | +2,24 % | XORTX Therapeutics Inc. GAAP EPS of -$1.05 | ||
| SOLIGENIX | 0,380 | +0,21 % | SOLIGENIX, INC.: Soligenix Announces Recent Updates and Second Quarter 2026 Financial Results | PRINCETON, N.J., Aug. 7, 2026 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a biopharmaceutical company focused on developing and commercializing... ► Artikel lesen | |
| TALPHERA | 1,000 | -4,76 % | Talphera, Inc.: Talphera Announces First Quarter 2026 Financial Results and Provides Corporate Update | NEPHRO CRRT clinical study expected to be completed this year
Cash and investments of $21.1 million at March 31, 2026
Conference call and webcast to be held on Wednesday... ► Artikel lesen | |
| SAVARA | 4,811 | +1,99 % | Savara Inc.: Savara Announces Encore Presentations of Results from the Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (APAP) at the European Respiratory Society (ERS) Congress 2026 | -- Company to Host Industry Evening Mini-Symposium on aPAP with Renowned Key Opinion Leaders --Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases... ► Artikel lesen | |
| SCYNEXIS | 4,990 | +5,83 % | SCYNEXIS Announces Inducement Award Under Nasdaq Listing Rule 5635(c)(4) | ||
| THERIVA BIOLOGICS | 0,260 | 0,00 % | Theriva Biologics, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| WAVE LIFE SCIENCES | 4,400 | -0,79 % | Wave Life Sciences Ltd.: Wave Life Sciences Announces Completion of Redomiciliation to Delaware | CAMBRIDGE, Mass., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (NASDAQ: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform... ► Artikel lesen | |
| TUHURA BIOSCIENCES | 1,810 | 0,00 % | TuHURA Biosciences, Inc./NV - 8-K, Current Report | ||
| THERAPEUTICSMD | 1,890 | +1,07 % | TherapeuticsMD, Inc. - 10-Q, Quarterly Report | ||
| SKYE BIOSCIENCE | 1,704 | -1,05 % | XFRA ISIN CHANGE | Einstellung Aufnahme ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: AnmerkungenCA0976924047 Bolt Metals Corp. 21.08.2026 CA90140G1063 26 Metals Inc. 24.08.2026 Tausch 1:1CA62430M1014 Mountain Valley... ► Artikel lesen |
TURN THERAPEUTICS INC gehört der Branche Pharma an. Der aktuelle Kurs liegt bei 10,080 Euro und damit -0,30 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu TURN THERAPEUTICS INC finden Sie auf Wallstreet Online.